Stock Chart

CRVO

$2.43 +0.83%
Score: 45.7 HOLD
Pro
Screener
Vol: 0.13x (vs SPY: 0.9x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 22, 2026
Falling Channel weak / forming — below our quality gate quality 55/100
A Falling Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About CRVO - CervoMed Inc. Common Stock

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Key Statistics

Market Cap $37M

More CRVO Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This CRVO stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track CRVO's price movements with trendlines, gamma walls, and key support/resistance levels.